![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Lupin largest drug maker buys 21 generic brands from Shionogi & Co to strengthen...
Lupin Ltd, India’s third largest drug maker, will buy a portfolio of 21 generic brands...
Pfizer adds to list of drugmakers under lens for deviating from good manufacturing practices
Pfizer is the latest addition to an expanding list of drug makers found deviating from...
Community verified biological network models show promise for toxicology and drug discovery
A new set of community-produced biological network models has been shown to allow a deeper...
Stem Cells May Speed Up Screening of Drugs for Rare Cancers
Researchers at the Johns Hopkins Kimmel Cancer Center say they have developed a system that...
Sun Pharma rolls out first ready to administer anti cancer drug in six European...
Sun Pharma, India's largest drug company has rolled out InfuSMART the first ever ready to...
The Anti-Counterfeit Drug Issue; It’s Real
Legislation is being put into place, but it is still essential that we all play...
Fighting Cancer with targeted Drugs
“Diagnosis cancer” – this is a life-changing moment for many people. After cardiovascular diseases, cancer...
Takeda Pharmaceutical Company Licenses Global Rights to Theravance Biopharma’s TD-8954
Takeda and Theravance Biopharma, Inc. announced that the companies have entered into a global license,...
GSKs Bexsero achieves primary and secondary endpoints with reduced 3-dose schedule in safety and...
GSK presented new data for its meningococcal group B vaccine, Bexsero®,1 comparing safety and...
Nplate Study In The Lancet Shows Significant Increase In Durable Platelet Response Among Children...
Amgen announced that The Lancet published results from a Phase 3 randomized, double-blind, placebo-controlled study...